Algentech Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $548K
Latest Deal Amount
  • Investors
  • 3

Algentech General Information


Developer of plant gene-editing technology designed for industrial and research applications. The company's proprietary technologies form unique tools for the precise engineering of nuclear and organelle (chloroplast and mitochondria) genomes, thereby enabling agriculture organizations to avoid nuclear transgene insertion and generation of cytoplasmic male sterility lines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • 4 Rue Pierre Fontaine
  • 91058 Évry
  • France

Algentech Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Algentech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 09-May-2018 $548K 00.000 00.000 Completed Generating Revenue
2. Later Stage VC 02-Mar-2018 00000 00000 00.000 Completed Generating Revenue
1. Angel (individual) 01-Jul-2012 $251K $251K Completed Startup
To view Algentech’s complete valuation and funding history, request access »

Algentech Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 0.000
To view Algentech’s complete cap table history, request access »

Algentech Executive Team (2)

Name Title Board Seat Contact Info
Alexander Sorokin Co-Founder, Chief Executive Officer & President
Isabelle Malcuit Ph.D Co-Founder, Chief Scientific Officer & Director
To view Algentech’s complete executive team members history, request access »

Algentech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Algentech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Scientipole Capital Venture Capital Minority 000 0000 000000 0
Investisseurs privés Corporation Minority 000 0000 000000 0
XMP Business Angelis Angel Group Minority 000 0000 000000 0
To view Algentech’s complete investors history, request access »